Cutler Group LP Crispr Therapeutics Ag Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Cutler Group LP holds 700 shares of CRSP stock, worth $34,853. This represents 0.02% of its overall portfolio holdings.

Number of Shares

700

Previous 200 250.0%

Holding current value

$34,853

Previous $12,000 291.67%

% of portfolio

0.02%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$60.67 - $89.12 $30,335 - $44,560	500 Added 250.0%	700 $47,000
Q4 2023 Jan 18, 2024	SELL	$38.62 - $72.18 $69,516 - $129,924	-1,800 Reduced 90.0%	200 $12,000
Q3 2023 Nov 07, 2023	SELL	$45.39 - $59.0 $39,035 - $50,740	-860 Reduced 30.07%	2,000 $90,000
Q2 2023 Jul 18, 2023	BUY	$43.47 - $67.77 $93,895 - $146,383	2,160 Added 308.57%	2,860 $160,000
Q1 2023 May 01, 2023	BUY	$41.0 - $56.12 $28,700 - $39,284	700 New	700 $31,000
Q3 2022 Oct 25, 2022	SELL	$61.1 - $83.78 $15,091 - $20,693	-247 Reduced 1.93%	12,553 $820,000
Q2 2022 Aug 04, 2022	SELL	$43.23 - $73.83 $461,177 - $787,618	-10,668 Reduced 45.46%	12,800 $777,000
Q1 2022 Apr 14, 2022	BUY	$53.19 - $79.24 $38,828 - $57,845	730 Added 3.21%	23,468 $1.47 Million
Q4 2021 Jan 18, 2022	BUY	$70.09 - $111.29 $689,545 - $1.09 Million	9,838 Added 76.26%	22,738 $1.72 Million
Q3 2021 Oct 26, 2021	BUY	$110.2 - $156.64 $255,664 - $363,404	2,320 Added 21.93%	12,900 $1.44 Million
Q2 2021 Jul 19, 2021	BUY	$100.84 - $161.89 $260,167 - $417,676	2,580 Added 32.25%	10,580 $1.71 Million
Q1 2021 Apr 26, 2021	SELL	$110.72 - $210.04 $527,027 - $999,790	-4,760 Reduced 37.3%	8,000 $974,000
Q4 2020 Jan 21, 2021	BUY	$79.67 - $173.23 $984,721 - $2.14 Million	12,360 Added 3090.0%	12,760 $1.95 Million
Q3 2020 Oct 27, 2020	SELL	$78.5 - $100.64 $31,400 - $40,256	-400 Reduced 50.0%	400 $33,000
Q1 2020 May 07, 2020	SELL	$33.68 - $62.53 $43,784 - $81,289	-1,300 Reduced 61.9%	800 $33,000
Q4 2019 Feb 06, 2020	SELL	$36.68 - $73.13 $146,609 - $292,300	-3,997 Reduced 65.56%	2,100 $127,000
Q1 2018 May 11, 2018	BUY	$23.52 - $58.17 $129,289 - $319,760	5,497 Added 916.17%	6,097 $278,000
Q3 2017 Oct 17, 2017	BUY	$16.75 - $20.66 $10,050 - $12,396	600	600 $10,000

Others Institutions Holding CRSP

# of Institutions

500

Shares Held

57M

Call Options Held

1.71M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account